SCHEMBL4608144

SCHEMBL4608144

NC(=O)C1CCCC1c1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 1/20 0.50
NR3C2 P08235 1/20 0.47
HRH3 Q9Y5N1 2/20 0.46
KDM1A O60341 2/20 0.44
SIGMAR1 Q99720 2/20 0.42
KCNH2 Q12809 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.40
SIRT1 Q96EB6 1/20 0.40
SLC6A2 P23975 4/20 0.40
SLC6A4 P31645 3/20 0.40
SLC6A3 Q01959 3/20 0.40
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607106 0.85 SLC6A4 (0.43) SLC9A1NR3C2HRH3KDM1ASIRT2
SCHEMBL4608244 0.84 SIRT2 (0.40) SLC9A1NR3C2HRH3SIRT2SIRT1
SCHEMBL3648971 0.84 SMN1; SMN2 (0.48) SLC9A1NR3C2HRH3KDM1ASIGMAR1
SCHEMBL4606744 0.83 KDM1A (0.43) SLC9A1NR3C2KDM1ASLC6A2SLC6A4
SCHEMBL4606990 0.83 ALDH1A1 (0.49) KDM1ASIRT2SIRT1SLC6A2SLC6A4
SCHEMBL4608380 0.83 SIRT2 (0.52) SLC9A1SIRT2SIRT1
SCHEMBL4371167 0.83 SLC6A4 (0.43) HRH3SIRT2SIRT1SLC6A2SLC6A4
SCHEMBL4371164 0.83 SLC6A4 (0.43) HRH3SIRT2SIRT1SLC6A2SLC6A4
SCHEMBL4605333 0.83 HRH3 (0.46) HRH3KDM1AKCNH2SIRT2SIRT1
SCHEMBL4606839 0.82 KCNQ3 (0.50) SLC9A1HRH3KDM1ASIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP claimed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US claimed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP claimed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO claimed
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP disclosed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US disclosed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP disclosed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO disclosed